UPDATE 1-Bayer's Regorafenib gets FDA fast-track designation

tumors, the German drugmaker said on Tuesday. The U.S. Food and... (Adds details, background) The U.S. Food and Drug Administration's fast-track status is designed to expedite the review of drugs to treat serious diseases and fill unmet medical needs....